申请人:Johnson Matthey Public Limited Company
公开号:US04394319A1
公开(公告)日:1983-07-19
The compound ##STR1## useful for the chemotherapeutic treatment of cancer or malignant neoplasms is provided in substantially pure form by a method of preparation involving a novel intermediate adduct with dimethylacetamide.
本发明提供了一种化合物## STR1##,其在治疗癌症或恶性肿瘤方面具有化疗作用,并通过一种制备方法以与二甲基乙酰胺的新型中间加合物的形式提供了该化合物的基本纯形式。